An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
Recruiting now
Conditions studied: Non-small Cell Lung Cancer
In brief
This study is focused on patients with non-small cell lung cancer (NSCLC) and have been prescribed a cemiplimab (Libtayo®) based treatment regimen under standard care. The goal of this study is to learn more about the use, benefits, and safety of cemiplimab based treatment regimens in participants with NSCLC.
Key facts
- Study ID
- NCT05363319
- Run by
- Regeneron Pharmaceuticals
- People needed
- 500
- Starts
- 2022-10-26
- Expected to finish
- 2028-10-30
- Last updated by the study team
- 2026-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hospital Universitari Sant Joan de Reus — Tarragona, Spain (enrolling)
- Salzburger Landeskliniken (SALK) — Salzburg, Austria (enrolling)
- Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital — Mulhouse, Alsace, France (enrolling)
- Hopitaux Universitaires de Strasbourg — Strasbourg, Bas-Rhin, France (enrolling)
- APHM - Hopital Nord — Marseille, Bouches-du-Rhône, France (enrolling)
- Sainte Catherine Institut du Cancer Avignon Provence — Avignon, Vaucluse, France (enrolling)
- Centre Hospitalier Universitaire (CHU) de Poitiers — Poitiers, Vienne, France (enrolling)
- Centre Hospitalier Universitaire Angers — Angers, France (enrolling)
- Hospital Torrecardenas — Almería, Spain (enrolling)
- University Hospital of Jaen — Jaén, Spain (enrolling)
- Hospital Arnau de Vilanova — Lleida, Spain (enrolling)
- Hospital Universitario Nuestra Senora de Candelaria — Santa Cruz de Tenerife, Spain (enrolling)
- Klinikum Klagenfurt — Klagenfurt, Carinthia, Austria (enrolling)
- Centre Hospitalier - Le mans — Le Mans, France (enrolling)
- Hopital Tenon — Paris, France (enrolling)
- Klinikum Konstanz — Konstanz, Baden-Wurttemberg, Germany (enrolling)
- Staedtisches Klinikum Muenchen Bogenhausen — München, Bavaria, Germany (enrolling)
- Franziskus Hospital Harderberg — Georgsmarienhütte, Georgsmarienhuette, Germany (enrolling)
- Agaplesion Diakonieklinikum Rotenburg — Rotenburg (Wümme), Lower Saxony, Germany (enrolling)
- St. Franziskus Hospital Münster — Münster, North Rhine-Westphalia, Germany (enrolling)
- Haematologisch Onkologische Schwerpunktpraxis - Troisdorf — Troisdorf, North Rhine-Westphalia, Germany (enrolling)
- Pneumologische Praxis PD Dr. Med Christian Gessner — Leipzig, Saxony, Germany (enrolling)
- Gemeinschaftskrankenhaus Havelhoehe — Berlin, Germany (enrolling)
- Gesellschaft fur Onkologische Studien Dortmund mbH (Gefos) — Dortmund, Germany (enrolling)
- Krankenhaus Martha-Maria Halle-Doelau gGmbH — Halle, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.